LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 18.04 | 21.74 | 1196 | 750 | 1.5935 | 1.1909 | MN20160310_N01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 18.04 | 21.74 | 710 | 750 | 0.9460 | 0.9784 | MN20160310_N01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 18.04 | 21.74 | 1560 | 750 | 2.0784 | 1.3079 | MN20160310_N01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 20.01 | 21.74 | 56 | 901 | 0.0621 | 0.1925 | MN20160310_N01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 20.01 | 21.74 | 1321 | 901 | 1.4646 | 1.1472 | MN20160310_N01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 20.01 | 21.74 | 1417 | 901 | 1.5711 | 1.1754 | MN20160310_N01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 20.01 | 21.74 | 1783 | 901 | 1.9769 | 1.2704 | MN20160310_N01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 21.98 | 21.74 | 189 | 1108 | 0.1705 | 0.4642 | MN20160310_N01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 21.98 | 21.74 | 1435 | 1108 | 1.2947 | 1.0932 | MN20160310_N01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 21.98 | 21.74 | 1731 | 1108 | 1.5618 | 1.1635 | MN20160310_N01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 21.98 | 21.74 | 1892 | 1108 | 1.7070 | 1.1977 | MN20160310_N01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 23.95 | 21.74 | 347 | 1354 | 0.2562 | 0.5915 | MN20160310_N01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 23.95 | 21.74 | 1562 | 1354 | 1.1531 | 1.0484 | MN20160310_N01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 23.95 | 21.74 | 1942 | 1354 | 1.4337 | 1.1246 | MN20160310_N01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 23.95 | 21.74 | 2010 | 1354 | 1.4839 | 1.1369 | MN20160310_N01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 25.92 | 21.74 | 516 | 1515 | 0.3405 | 0.6773 | MN20160310_N01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 25.92 | 21.74 | 1696 | 1515 | 1.1190 | 1.0371 | MN20160310_N01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 25.92 | 21.74 | 2114 | 1515 | 1.3948 | 1.1117 | MN20160310_N01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 25.92 | 21.74 | 2173 | 1515 | 1.4337 | 1.1212 | MN20160310_N01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 27.89 | 21.74 | 616 | 1677 | 0.3673 | 0.7047 | MN20160310_N01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 27.89 | 21.74 | 1867 | 1677 | 1.1133 | 1.0345 | MN20160310_N01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 27.89 | 21.74 | 2323 | 1677 | 1.3852 | 1.1067 | MN20160310_N01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 27.89 | 21.74 | 2394 | 1677 | 1.4275 | 1.1168 | MN20160310_N01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 29.86 | 21.74 | 982 | 1887 | 0.5204 | 0.8071 | MN20160310_N01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 29.86 | 21.74 | 2071 | 1887 | 1.0975 | 1.0291 | MN20160310_N01 | E09 |